D. Wendling

发表

Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)

M. Dougados, A. Saraux, P. Goupille, 2023, RMD Open.

Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology

F Guillemin, B Combe, F. Guillemin, 2005, Annals of the rheumatic diseases.

ASAS/EULAR recommendations for the management of ankylosing spondylitis

M. Dougados, S. van der Linden, B. Dijkmans, 2005, Annals of the rheumatic diseases.

Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis.

P. Tiberghien, N. Balandraud, J. Roudier, 2001, Arthritis and rheumatism.

Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis.

F. Aubin, D. Wendling, G. Dumoulin, 2005, Rheumatology.

Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis

P. Garnero, J. Sany, D. Wendling, 2007, Annals of the rheumatic diseases.

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

M. Dougados, B. Dijkmans, I. Olivieri, 2011, Annals of the rheumatic diseases.

Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the Autoimmunity and Rituximab Registry

X. Mariette, J. Gottenberg, L. Gossec, 2012, Arthritis care & research.

Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome

X. Mariette, W. Ng, Z. Amoura, 2016, Arthritis & rheumatology.

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

F. Tubach, P. Ravaud, X. Mariette, 2010, Annals of the rheumatic diseases.

High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies

P. Tiberghien, P. Saas, D. Wendling, 2003, Clinical and experimental immunology.

French guidelines for the management of chikungunya (acute and persistent presentations). November 2014.

B. Hoen, F. Djossou, D. Malvy, 2015, Medecine et maladies infectieuses.

Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial

G. Baron, P. Ravaud, D. Loeuille, 2014, Annals of the rheumatic diseases.

Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis.

D. Wendling, J. Wijdenes, E. Racadot, 1991, The Journal of rheumatology.

Rheumatic disorders developed after hepatitis B vaccination.

E. Vignon, J. Sibilia, D. Wendling, 1999, Rheumatology.

Treatment of rheumatoid arthritis with anti CD4 monoclonal antibody. Open study of 25 patients with the B-F5 clone

J. Wijdenes, E. Racadot, B. Morel-Fourrier, 1992, Clinical Rheumatology.

Immunological follow-up of 17 patients with rheumatoid arthritis treated in vivo with an anti-T CD4+ monoclonal antibody (B-F5)

J. Wijdenes, E. Racadot, D. Wendling, 1992, Clinical and Experimental Rheumatology.

Use of Monoclonal Antibodies in vivo as a Therapeutic Strategy for Alloimmune or Autoimmune Reactivity: The Besançon Experience

L. Rumbach, P. Tiberghien, P. Hervé, 1992, Immunological reviews.

Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy

D. Bettinger, G. Herbein, D. Wendling, 2005, Annals of the rheumatic diseases.

Adult onset Still's disease and related renal amyloidosis.

T. Fest, P. Humbert, C. Billerey, 1991, Annals of the rheumatic diseases.

Adult Still's disease and mesangial glomerulonephritis. Report of two cases

D. Wendling, B. Hory, D. Blanc, 1990, Clinical Rheumatology.

HLA-DRB1 alleles and shared amino acid sequences in disease susceptibility and severity in patients from eastern France with rheumatoid arthritis.

P. Tiberghien, D. Wendling, E. Toussirot, 1999, The Journal of rheumatology.

Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospital.

Y. Allanore, J. Avouac, A. Moltó, 2023, Rheumatology.

Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study.

M. Dougados, E. Vignon, E. Lespessailles, 2002, Rheumatology.

OP0022 RISK OF DIVERTICULITIS AND GASTRO-INTESTINAL PERFORATION IN RHEUMATOID ARTHRITIS TREATED WITH TOCILIZUMAB COMPARED TO RITUXIMAB AND ABATACEPT: A PROSPECTIVE PROPENSITY-MATCHED COHORT STUDY

X. Mariette, B. Combe, T. Pham, 2020, Annals of the Rheumatic Diseases.

Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up.

M. Dougados, E. Vignon, E. Lespessailles, 2006, Rheumatology.

Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry

M. Dougados, X. Mariette, J. Gottenberg, 2010, Annals of the rheumatic diseases.

Safety of Surgery After Rituximab Therapy in 133 Patients With Rheumatoid Arthritis: Data From the AutoImmunity and Rituximab Registry

P. Ravaud, X. Mariette, F. Berenbaum, 2013, Arthritis care & research.

Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the Autoimmunity and Rituximab Registry

X. Mariette, J. Gottenberg, L. Gossec, 2012, Arthritis care & research.

Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis.

S. Ricard-Blum, D. Wendling, G. Dumoulin, 1999, Rheumatology.

Prospective study of the prevalence of bronchiectasis in rheumatoid arthritis using high-resolution computed tomography.

D. Wendling, E. Toussirot, P. Manzoni, 1998, Revue du rhumatisme.

Non-radiographic axial spondyloarthritis: what is it?

D. Wendling, P. Claudepierre, C. Poulain, 2014, Clinical and experimental rheumatology.